-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Initiates Coverage On Vor Biopharma with Buy Rating, Announces Price Target of $50

Benzinga·03/30/2026 12:44:44
Listen to the news
Jefferies analyst Farzin Haque initiates coverage on Vor Biopharma (NASDAQ:VOR) with a Buy rating and announces Price Target of $50.